NCT07088783Completed
The Effect of Mobile Application-Based Education Developed According to Orem's Self-Care Model in Multiple Myeloma Patients
THE EFFECT OF A MOBILE APPLICATION-BASED EDUCATION DEVELOPED ACCORDING TO OREM'S SELF-CARE MODEL ON THE IMPROVEMENT OF SELF-CARE AGENCY IN PATIENTS WITH MULTIPLE MYELOMA: A RANDOMIZED CONTROLLED TRIAL
Source: ClinicalTrials.gov · Last updated 21 Oct 2026
Brief summary (registry, in English)
This randomized controlled trial aims to assess the effectiveness of a mobile application-based education program, developed according to Orem's Self-Care Model, in improving self-care agency and quality of life among patients with multiple myeloma in Turkey. Participants are recruited from the outpatient clinic of a hospital and randomly assigned to either the intervention or control group. The intervention group uses the mobile application for 24 weeks, while the control group continues with routine care and receives a standard one-page brochure commonly distributed to cancer patients. All participants complete a demographic form, the EORTC QLQ-C30, QLQ-MY20, and the Self-Care Agency Scale at baseline, week 12, and week 24. The collected data will be used to compare changes in self-care agency and quality of life between the two groups over time.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 59 (actual)
- First submitted
- 19 Jul 2025
- Start date
- 1 Jun 2024
- Primary completion date
- 1 Sept 2025
- Lead sponsor
- Ozlem
- Diseases
- Multiple myeloma, Childhood cancers
- NCT number
- NCT07088783
What you commit to
- Study type: Interventional
- Participants enrolled: 59
- From 1 Jun 2024 to the primary completion date, 1 Sept 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Has cognitive or psychological disorders that prevent completing questionnaires or using the mobile application
Other
- Not currently diagnosed with multiple myeloma
- Unable to speak or understand Turkish
- Unwilling or unable to provide written informed consent
Who the study is looking for
- Diagnosed with multiple myeloma and received at least one course of treatment
- Age 18 or older
- Able to speak and read Turkish
- ECOG performance status of I, II, or III
- Has used at least one Android-based digital tool (e.g., sending text messages, email, using mobile apps)
- Literate (able to read and write)
- Willing to participate and able to provide written informed consent
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dokuz Coordinator of this site? Confirm its status | Izmir | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.